Oxford Immunotec
A medical diagnostics company, develops tests for various diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€102—153m (Dealroom.co estimates Jun 2012.)
Share price
$21.99 OXFD
Company register number 04516079
Milton England (HQ)
Financials
Estimates*
USD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | - | 54.0m | 59.0m | 73.0m | 58.0m | 82.0m | 94.0m |
% growth | - | - | 9 % | 24 % | (21 %) | 41 % | 15 % |
EBITDA | 11.0m | 27.0m | 16.0m | 3.0m | (13.0m) | (3.0m) | (26.1m) |
% EBITDA margin | - | 50 % | 27 % | 4 % | (22 %) | (4 %) | (28 %) |
Profit | 4.4m | 32.0m | 121m | 1.0m | (15.0m) | (2.0m) | 2.0m |
% profit margin | - | 59 % | 205 % | 1 % | (26 %) | (2 %) | 2 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
£2.5m | Series A | ||
£7.0m | Series B | ||
$40.0m | Series C | ||
$26.0m | Series D | ||
$28.0m | Late VC | ||
* | N/A | $12.0m | Debt |
N/A | $64.3m | IPO | |
* | N/A | $53.7m | Post IPO Equity |
$40.0m | Post IPO Debt | ||
N/A | Acquisition | ||
Total Funding | €96.9m |
Recent News about Oxford Immunotec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Oxford Immunotec
EditACQUISITION by Oxford Immunotec Oct 2016
ACQUISITION by Oxford Immunotec Jun 2016